No summary has been written for this.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about ARKT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
ARK DIET Q4 Buffer ETF is an actively managed exchange-traded fund designed to provide a defined outcome tied to the performance of the ARK Innovation ETF. It seeks to combine exposure to disruptive innovation themes with a built-in buffer that limits investors’ participation in downside moves to roughly half of any decline in the reference asset over each outcome period. At the same time, the fund is structured to capture upside only after a preset hurdle rate is reached, using an options-overlay approach to shape returns. The ETF is part of ARK’s DIET suite, which focuses on quarterly outcome periods and gives the fund a role in the defined-outcome ETF market. Its structure makes it distinct from traditional equity ETFs by emphasizing a pre-set risk-return profile rather than broad market tracking.
The latest articles about ARKT.
MINNEAPOLIS, October 01, 2026--Allianz Investment Management LLC (AllianzIM), a wholly owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life), a registered investment adviser and adviser to AllianzIM exchange-traded funds (ETFs), today announced the expansion of its Buffered ETF lineup with the launch of the AllianzIM International Equity Buffer15 Uncapped Oct ETF (OCTI), a new strategy seeking to provide investors with an additional entry point to maintain internatio
NEW YORK, August 25, 2026--VanEck and Lido Advisors partner to launch first in a planned suite of defined outcome funds, the VanEck U.S. Equity Buffer ETF – July (JULV).